Bouwien E. Smid

1.2k total citations
13 papers, 860 citations indexed

About

Bouwien E. Smid is a scholar working on Physiology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Bouwien E. Smid has authored 13 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 8 papers in Epidemiology and 4 papers in Organic Chemistry. Recurrent topics in Bouwien E. Smid's work include Lysosomal Storage Disorders Research (13 papers), Trypanosoma species research and implications (8 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Bouwien E. Smid is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Trypanosoma species research and implications (8 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Bouwien E. Smid collaborates with scholars based in Netherlands, Germany and Canada. Bouwien E. Smid's co-authors include Carla E. M. Hollak, Gabor E. Linthorst, Ben J. H. M. Poorthuis, Linda van der Tol, Saskia M. Rombach, Marcel G. W. Dijkgraaf, Ronald H. Lekanne Deprez, M. Biegstraaten, Marieke Biegstraaten and Johannes M. F. G. Aerts and has published in prestigious journals such as Kidney International, Journal of Medical Genetics and International Journal of Cardiology.

In The Last Decade

Bouwien E. Smid

13 papers receiving 837 citations

Peers

Bouwien E. Smid
Severo Pagliardini Italy
Robert Dobrovolný Czechia
Margaret Timmons United States
Carmela Zizzo Italy
Alexander Broomfield United Kingdom
Miriam Rigoldi Italy
Sebastiaan J.M. Gaemers United States
Hadhami Ben Turkia Tunisia
Hana Vlášková Czechia
Ana Marcão Portugal
Severo Pagliardini Italy
Bouwien E. Smid
Citations per year, relative to Bouwien E. Smid Bouwien E. Smid (= 1×) peers Severo Pagliardini

Countries citing papers authored by Bouwien E. Smid

Since Specialization
Citations

This map shows the geographic impact of Bouwien E. Smid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bouwien E. Smid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bouwien E. Smid more than expected).

Fields of papers citing papers by Bouwien E. Smid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bouwien E. Smid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bouwien E. Smid. The network helps show where Bouwien E. Smid may publish in the future.

Co-authorship network of co-authors of Bouwien E. Smid

This figure shows the co-authorship network connecting the top 25 collaborators of Bouwien E. Smid. A scholar is included among the top collaborators of Bouwien E. Smid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bouwien E. Smid. Bouwien E. Smid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Smid, Bouwien E., María Pía Ferraz, Marri Verhoek, et al.. (2016). Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients. Orphanet Journal of Rare Diseases. 11(1). 28–28. 51 indexed citations
2.
Smid, Bouwien E., Linda van der Tol, Marieke Biegstraaten, et al.. (2015). Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. Journal of Medical Genetics. 52(4). 262–268. 118 indexed citations
3.
Shu, Liming, Anuradha Vivekanandan‐Giri, Subramaniam Pennathur, et al.. (2014). Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease. Kidney International. 86(1). 58–66. 74 indexed citations
4.
Smid, Bouwien E., Linda van der Tol, Franco Cecchi, et al.. (2014). Uncertain diagnosis of Fabry disease: Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. International Journal of Cardiology. 177(2). 400–408. 109 indexed citations
5.
Smid, Bouwien E., et al.. (2014). Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy. Journal of Inherited Metabolic Disease. 38(2). 351–358. 17 indexed citations
6.
Smid, Bouwien E., Linda van der Tol, Franco Cecchi, et al.. (2014). Consensus recommendation on Fabry disease diagnosis in adult patients with left ventricular hypertrophy. Molecular Genetics and Metabolism. 111(2). S99–S99. 2 indexed citations
7.
Rombach, Saskia M., Bouwien E. Smid, Gabor E. Linthorst, Marcel G. W. Dijkgraaf, & Carla E. M. Hollak. (2014). Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta‐analysis. Journal of Inherited Metabolic Disease. 37(3). 341–352. 88 indexed citations
8.
Smid, Bouwien E., Carla E. M. Hollak, Ben J. H. M. Poorthuis, et al.. (2014). Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance. Clinical Genetics. 88(2). 161–166. 47 indexed citations
9.
Smid, Bouwien E. & Carla E. M. Hollak. (2014). A systematic review on effectiveness and safety of eliglustat for type 1 Gaucher disease. Expert Opinion on Orphan Drugs. 2(5). 523–529. 12 indexed citations
10.
Rombach, Saskia M., Bouwien E. Smid, Machtelt G. Bouwman, et al.. (2013). Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain. Orphanet Journal of Rare Diseases. 8(1). 47–47. 124 indexed citations
11.
Tol, Linda van der, Bouwien E. Smid, Ben J. H. M. Poorthuis, et al.. (2013). A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. Journal of Medical Genetics. 51(1). 1–9. 137 indexed citations
12.
Smid, Bouwien E., et al.. (2012). A revised home treatment algorithm for Fabry disease: Influence of antibody formation. Molecular Genetics and Metabolism. 108(2). 132–137. 28 indexed citations
13.
Smid, Bouwien E., Saskia M. Rombach, Johannes M. F. G. Aerts, et al.. (2011). Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients. Orphanet Journal of Rare Diseases. 6(1). 69–69. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Severo Pagliardini Breakdown of academic impact, for papers by Robert Dobrovolný Breakdown of academic impact, for papers by Margaret Timmons Breakdown of academic impact, for papers by Carmela Zizzo Breakdown of academic impact, for papers by Alexander Broomfield Breakdown of academic impact, for papers by Miriam Rigoldi Breakdown of academic impact, for papers by Sebastiaan J.M. Gaemers Breakdown of academic impact, for papers by Hadhami Ben Turkia Breakdown of academic impact, for papers by Hana Vlášková Breakdown of academic impact, for papers by Ana Marcão
Rankless by CCL
2026